Number of items: 5.
2024
Copland, A. et al.
(2024)
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity.
EMBO Molecular Medicine, 16(12),
pp. 3057-3088.
(doi: 10.1038/s44321-024-00159-2)
(PMID:39558103)
(PMCID:PMC11628626)
2023
Fisch, D. et al.
(2023)
PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.
Science, 382(6666),
eadg2253.
(doi: 10.1126/science.adg2253)
(PMID:37797010)
(PMCID:PMC7615196)
2022
Bombaci, G. et al.
(2022)
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.
Life Science Alliance, 5(6),
e202101226.
(doi: 10.26508/lsa.202101226)
(PMID:35256513)
(PMCID:PMC8922048)
2021
Mackie, Gillian M., Copland, Alastair, Takahashi, Masumi, Nakanishi, Yumiko, Everard, Isabel, Kato, Tamotsu, Oda, Hirotsugu, Kanaya, Takashi, Ohno, Hiroshi and Maslowski, Kendle M.
ORCID: https://orcid.org/0000-0003-1995-5424
(2021)
Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape.
JCI Insight, 6(23),
e139900.
(doi: 10.1172/jci.insight.139900)
(PMID:34710062)
(PMCID:PMC8675204)
Elliot, Thomas A.E., Jennings, Emma K., Lecky, David A.J., Natash, Natasha, Flores-Langarica, Adriana, Copland, Alastair, Maslowski, Kendle M.
ORCID: https://orcid.org/0000-0003-1995-5424, Wraith, David C. and Bending, David
(2021)
Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength.
Immunity, 54(11),
2481-2496.e6.
(doi: 10.1016/j.immuni.2021.08.020)
(PMID:34534438)
(PMCID:PMC8585507)
This list was generated on Fri Feb 20 12:19:40 2026 GMT.